Evidence mapPaperPMID 42466351Full record

ReviewFrontiers in endocrinology2026

Lymphatic dysfunction and impaired interstitial clearance in sarcopenic obesity: a hypothesis-generating review.

Chunli Yu, Xinyu Zou, Rongli Dai, Yan Yang

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chunli YuDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Xinyu ZouDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Rongli DaiDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yan YangDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcopenic obesity (SO) is characterized by excess adiposity together with reduced skeletal muscle mass and impaired muscle function, and primarily affects older adults. Its pathogenesis involves chronic low-grade inflammation, insulin resistance, ectopic lipid accumulation, mitochondrial dysfunction, and disrupted skeletal muscle homeostasis. Current models mainly explain how inflammatory and metabolic signals are generated through adipose-muscle crosstalk, but less clearly address why these signals persist within the local interstitial environment. The lymphatic system maintains interstitial homeostasis by regulating tissue drainage, mediator clearance, immune trafficking, lipid transport, and microenvironmental renewal. In SO, ageing and obesity may jointly impair lymphatic function: obesity increases inflammatory, lipid, and metabolic lymphatic stress, whereas ageing lowers baseline lymphatic reserve. These abnormalities may sustain a pro-inflammatory, pro-lipotoxic, and repair-unfavorable interstitial milieu. In this review, we summarize ageing- and obesity-associated lymphatic abnormalities and propose a clearance-centered framework in which impaired lymphatic clearance amplifies local inflammation, lipid stress, insulin resistance, gut-muscle axis disturbance, and defective skeletal muscle repair in SO. Skeletal muscle deterioration may further weaken contraction-assisted lymphatic return, potentially reinforcing impaired clearance and local inflammatory-metabolic stress. This framework complements the adipose-muscle crosstalk model and highlights testable directions for future SO-specific studies.

Indexed as

Lymphatic SystemObesitySarcopeniaAdipose TissueAgingAnimalsHumansInflammationInsulin ResistanceMuscle, Skeletaladipose tissuechronic inflammationgut–muscle axisinsulin resistanceinterstitial fluidlymphatic dysfunctionsarcopenic obesityskeletal muscle

Identifiers

PMID42466351
PMCPMC13372616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.